• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一种用于快速识别急性髓系白血病中可测量残留病的机器学习方法。

A machine learning approach for the rapid identification of measurable residual disease in acute myeloid leukemia.

作者信息

Vahedi Amirali, Royaei Mohammadreza, Madani Tahereh, Mercier François, Poopak Behzad

机构信息

Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC, Canada; Lady Davis Institute for Medical Research, Montreal, QC.

Payvand Clinical, Specialty, Pathology, Medical Genetics and Molecular Laboratory, Tehran.

出版信息

Haematologica. 2025 Mar 6. doi: 10.3324/haematol.2024.286019.

DOI:10.3324/haematol.2024.286019
PMID:40045896
Abstract

Not available.

摘要

无法提供。

相似文献

1
A machine learning approach for the rapid identification of measurable residual disease in acute myeloid leukemia.一种用于快速识别急性髓系白血病中可测量残留病的机器学习方法。
Haematologica. 2025 Mar 6. doi: 10.3324/haematol.2024.286019.
2
Measurable residual disease (MRD) as a surrogate end point for clinical drug approval in acute myeloid leukemia (AML): Perspectives from the MRD Partnership and Alliance in AML Clinical Treatment Consortium.可测量残留病（MRD）作为急性髓系白血病（AML）临床药物批准的替代终点：AML临床治疗联盟MRD合作与联盟的观点
Cancer. 2025 Jul 1;131(13):e35960. doi: 10.1002/cncr.35960.
3
Measurable residual disease in hematologic malignancies: a biomarker in search of a standard.血液系统恶性肿瘤中的可测量残留病：寻求标准的生物标志物。
EClinicalMedicine. 2025 Jul 10;86:103348. doi: 10.1016/j.eclinm.2025.103348. eCollection 2025 Aug.
4
The clinical utility and prognostic value of next-generation sequencing for measurable residual disease assessment in acute myeloid leukemia.下一代测序在急性髓系白血病可测量残留病评估中的临床应用及预后价值
Ther Adv Hematol. 2025 Jun 26;16:20406207251349261. doi: 10.1177/20406207251349261. eCollection 2025.
5
Prognostic Value of Molecular Genetic Measurable Residual Disease (MRD) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10.
Eur J Haematol. 2025 Aug 13. doi: 10.1111/ejh.70019.
6
NPM1 Measurable Residual Disease: A Narrative Review.NPM1可测量残留病：一篇叙述性综述。
Indian J Hematol Blood Transfus. 2025 Jul;41(3):453-459. doi: 10.1007/s12288-025-01958-4. Epub 2025 Jan 27.
7
Single-cell immune landscape of measurable residual disease in acute myeloid leukemia.急性髓系白血病中可测量残留病的单细胞免疫景观。
Sci China Life Sci. 2024 Nov;67(11):2309-2322. doi: 10.1007/s11427-024-2666-8. Epub 2024 Jul 19.
8
Post-transplant cyclophosphamide and early mixed donor Chimerism in myeloid malignancies; a single-center experience.移植后环磷酰胺和早期混合供者嵌合体在髓系恶性肿瘤中的应用：单中心经验。
Transpl Immunol. 2023 Apr;77:101808. doi: 10.1016/j.trim.2023.101808. Epub 2023 Feb 24.
9
Prognostic significance of deep sequencing for analysis of measurable residual disease in acute myeloid leukemia with mutation.
Leuk Lymphoma. 2025 Aug;66(8):1487-1497. doi: 10.1080/10428194.2025.2482130. Epub 2025 Mar 31.
10
A Machine Learning-Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia.一种基于机器学习的策略可预测复发性急性髓系白血病的选择性和协同药物组合。
Cancer Res. 2025 Jul 15;85(14):2753-2768. doi: 10.1158/0008-5472.CAN-24-3840.

引用本文的文献

1
Applications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemia.机器学习在急性髓系白血病免疫表型可测量残留病评估中的应用
Hemasphere. 2025 May 21;9(5):e70138. doi: 10.1002/hem3.70138. eCollection 2025 May.

本文引用的文献

1
MAGIC-DR: An interpretable machine-learning guided approach for acute myeloid leukemia measurable residual disease analysis.MAGIC-DR：一种用于急性髓细胞白血病可测量残留病分析的可解释机器学习指导方法。
Cytometry B Clin Cytom. 2024 Jul;106(4):239-251. doi: 10.1002/cyto.b.22168. Epub 2024 Feb 28.
2
How I read an article that uses machine learning methods.我如何阅读一篇使用机器学习方法的文章。
Blood Adv. 2023 Aug 22;7(16):4550-4554. doi: 10.1182/bloodadvances.2023010140.
3
UMAP Based Anomaly Detection for Minimal Residual Disease Quantification within Acute Myeloid Leukemia.
基于UMAP的急性髓系白血病微小残留病定量异常检测
Cancers (Basel). 2022 Feb 11;14(4):898. doi: 10.3390/cancers14040898.
4
Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party.基于流式细胞术的急性髓系白血病微小残留病定量分析的技术要点：欧洲白血病网微小残留病工作组的经验
Hemasphere. 2021 Dec 22;6(1):e676. doi: 10.1097/HS9.0000000000000676. eCollection 2022 Jan.
5
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.2021 年急性髓系白血病微小残留病更新：来自欧洲白血病网微小残留病工作组的共识文件。
Blood. 2021 Dec 30;138(26):2753-2767. doi: 10.1182/blood.2021013626.
6
Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia.无监督流式细胞术分析可准确识别急性髓系白血病中的微小残留病评估。
Cancers (Basel). 2021 Feb 5;13(4):629. doi: 10.3390/cancers13040629.
7
Acute Myeloid Leukemia Minimal Residual Disease Detection: The Difference from Normal Approach.急性髓系白血病微小残留病灶检测：与常规方法的差异。
Curr Protoc Cytom. 2020 Jun;93(1):e73. doi: 10.1002/cpcy.73.
8
Machine Learning in Medicine.医学中的机器学习
N Engl J Med. 2019 Apr 4;380(14):1347-1358. doi: 10.1056/NEJMra1814259.
9
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome.用于检测急性髓系白血病和骨髓增生异常综合征中残留疾病的多色流式细胞术分析的临床验证机器学习算法。
EBioMedicine. 2018 Nov;37:91-100. doi: 10.1016/j.ebiom.2018.10.042. Epub 2018 Oct 22.
10
Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML.AML 中组合靶向治疗的白血病干细胞标志物的共表达谱。
Leukemia. 2019 Jan;33(1):64-74. doi: 10.1038/s41375-018-0180-3. Epub 2018 Jun 26.